Background/Aims: Bone marrow-derived mesenchymal stem cells (MSCs) are responsible for new bone formation during adulthood. Accumulating evidences showed that Osthole promotes the osteogenic differentiation in primary osteoblasts. The aim of this study was to investigate whether Osthole exhibits a potential to stimulate the osteogenic differentiation of MSCs and the underlying mechanism. Methods: MSCs were treated with a gradient concentration of Osthole (6.25 µM, 12.5 µM, and 25 µM). Cell proliferation was assessed by western blotting with the proliferating cell nuclear antigen (PCNA) and Cyclin D1 antibodies, fluorescence activated cell sorting (FACS), and cell counting kit 8 (CCK8). MSCs were cultured in osteogenesis-induced medium for one or two weeks. The osteogenic differentiation of MSCs was estimated by Alkaline Phosphatase (ALP) staining, Alizarin red staining, Calcium influx, and quantitative PCR (qPCR). The underlying mechanism of Osthole-induced osteogenesis was further evaluated by western blotting with antibodies in Wnt/β-catenin, PI3K/Akt, BMPs/ smad1/5/8, and MAPK signaling pathways. Results: Osthole inhibited proliferation of rat MSCs in a dose-dependent manner. Osthole suppressed osteogenic differentiation of rat MSCs by down-regulating the activities of Wnt/β-catenin and Erk1/2-MAPK signaling. Conclusions: Osthole inhibits the proliferation and osteogenic differentiation of rat MSCs, which might be mediated through blocking the Wnt/β-catenin and Erk1/2-MAPK signaling pathways.
Introduction
As the World Health Organization (WHO) experts defined, osteoporosis is a progressive systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture [1] .
Mesenchymal stem cells (MSCs) originating from bone marrow are described as a population of progenitor cells capable of osteogenic, adipogenic and chondrogenic differentiation [2, 3] . Clinical relevance of MSCs has been highlighted by their capacity for in vivo differentiation and engraftment, and eventually by their efficacy in promoting wound healing and tissue regeneration [4] [5] [6] . A detailed study of osteogenic differentiation in 2015 indicated that both systemic and local injection of allogeneic MSCs promotes fracture healing by optimizing biomechanical properties, bone content, and callus sizes [7] . Ovariectomized (OVX) mice exhibited delayed osteoporotic fracture healing because of the lower bone marrow and peripheral blood MSCs after fracture [8] .
Osthole, 7-methoxy-8-(3-methyl-2-butenyl) coumarin, is a coumarin derivative widely used in Traditional Chinese Medicine (TCM) [9] . It had been widely reported that Osthole exerts a significant positive effect on osteoporosis treatment by promoting osteoblast differentiation and inhibiting bone resorption [10] [11] [12] [13] [14] . Interestingly, a recent study on biomaterial suggested that Osthole stimulation may enhance extracellular matrix (ECM) production and positively affect cell behavior in cell sheet engineering of jaw bone marrow mesenchymal stem cells [15] . However, further studies investigating the impact of Osthole on the function of bone marrow-derived MSCs and the underlying mechanism remain quite limited.
Therefore, the purpose of the present study was to evaluate how Osthole affects the proliferation and osteogenic differentiation of rat bone marrow-derived MSCs. To the best of our knowledge, this investigation is the first to systematically elucidate the effect of Osthole on rat bone marrow-derived MSCs at the cellular and molecular levels.
Materials and Methods

Cell lines and culture
Rat primary MSCs were bought from Cyagen Company (Cyagen Biosciences Inc, Guangzhou, China), Basal medium for MSCs was supplemented with fetal bovine serum (FBS, RAWMX-05001-50, Cyagen) and penicillin-streptomycin (T150731G001, Cyagen). All media were changed every other day.
Osteogenic differentiation
Rat MSCs were seeded at 5 × 10 5 cells/well in 6-well plates in the maintenance medium. The medium was changed to osteogenic differentiation medium (RAWMX03021-175, Cyagen) the next day, which was supplemented with 10% FBS (RAWMX 05001-20, Cyagen), 10 mM β-glycerophosphate (T151112G001, Cyagen), 50 μg/ml of L-ascorbic acid (T151013G001, Cyagen), L-glutamine (T151021g001, Cyagen), and 10 -7 M dexamethasone (T151012G001, Cyagen). Rat MSCs were induced for one or two weeks for different purposes, and the medium was changed every other day.
Osthole-removal experiment. 12.5 μM Osthole was removed from the medium after 7 days of induction, and maintained in osteogenic differentiation medium for another 14 days (Osthole-R group). MSCs were induced in osteogenic medium alone for 21 days (control group) or supplemented with 12.5 μM Osthole for 21 days (Osthole group).
Cell density experiment. MSCs were seeded at the density of 5 × 10 4 /cm 2 (low, 70%-80% confluence), and induced in osteogenic differentiation medium alone or supplemented with 12.5 μM Osthole (control-L group or Osthole-L group). MSCs were seeded at the density of 7.5 × 10 4 /cm 2 (high, 100% confluence), and induced in osteogenic differentiation medium alone or supplemented with 12.5 μM Osthole ( control-H group or Osthole-H group).
Western blotting
MSCs were treated with Osthole for 24 hours and lysed with lysis buffer (Beyotime, P0013B) containing PMSF. Lysates was centrifuged at 12,000 g at 4°C for 10 min. Protein concentrations were determined using BCA Protein Assay Kit (Cat.No 23227, Pierce, USA). Proteins were separated by 10% SDS-PAGE and transferred to PVDF membrane using a standard protocol. The membrane was incubated with primary antibodies and probed with the respective secondary antibodies. The membrane was exposed and scanned using Odyssey ® Infrared Imaging system. The gray values of the resulting protein bands were quantified by using Image J software. The following antibodies were used: β-catenin (#9562, CST), TCF4 (#2569, CST), LEF1 (#2230, CST), GAPDH (#2118S,CST), PCNA (SC-25280, Santacruz), CyclinD1 (#2978, CST). MSCs were treated with Osthole for 1 hour, 2 hours and 3 hours and lysed with Nuclear and Cytoplasmic Protein Extraction reagent (Beyotime, P0027). The citoplasmic proteins were collected for detecting p-Erk1/2 (#9910, CST), Erk1/2 (#9102, CST), p-P38MARK (#9910, CST), P38MAPK (#9212, CST), Akt (#4691, CST), P-Akt-Ser473 (#4060, CST), P-Akt-Thr308 (#2965, CST), and P-Smad1 
ALP activity
Cells were induced for one week, and the Protein concentrations were determined using BCA Protein Assay Kit (Cat.No 23227, Pierce, USA). 20 ug of total proteins were mixed with 100 µL 1-step TM PNPP (Cat. No 37621, Pierce, USA), and then incubated at RT for 30 min. The reaction was stopped by addition of 50 µL of 2M NaOH. As a result, yellow p-nitrophenol (pNP) compound is formed, which is measured by a maximum absorbance at 405 nm.
Cell cycle distribution
To assess the effect of Osthole on cell cycle distribution, flow cytometric analysis of nuclear DNA content was performed by staining with propidium iodide (P4170, Sigma). In brief, Rat MSCs were seeded in a 6cm dish and then allowed to attach overnight. The medium was replaced with osteogenic medium containing desired concentrations of Osthole or dimethyl sulfoxide (DMSO, control). Cells were incubated for 24 hours at 37°C, and harvested and washed with 1×PBS three times, and then fixed by 70% ethanol overnight at 4°C. The cells were then treated with 100 μg/ml RNaseA and 100 μg/ml propidium iodide for 30 min at 37°C. Stained cells were transferred to FACS tubes and detected using a flow cytometry (Beckman Coulter).
Cell Counting Kit (CCK-8) assay
Cell proliferation was measured using CCK-8 assay (Dojindo, Japan). Rat MSCs were plated at the density of 3000 cells/well in 96-well plates with osteogenic differentiation medium in the presence of gradient concentrations of Osthole (6.25 µM, 12.5 µM, and 25 µM) for 24, 48, and 72 hours. After treatment, 10 μl CCK-8 solution was added to each well and cells were incubated for 0.5 h at 37˚C. The optical density of each well was measured using a microplate reader (SYNERGY4, USA) at a wavelength of 450 nm. At least three independent experiments were performed.
Intracellular calcium measurements
Cells were washed three times with HBSS solution (130 mM NaCl; 5 mM KCl; 1 mM MgCl 2 ; 1 mM CaCl 2 ; 10 mM glucose), and then loaded with 1 µM Ca
2+
-sensitive dye fluo4-AM molecular Probes (Dojindo, Japan). Subsequently, the cells were incubated with probe for 60 min and then washed three times with HBSS for probe removal. Cells were investigated under inverted fluorescence microscope or measured with microplate Reader (excitation wavelength at 485 nm and emission wavelength at 528 nm). The percentages of absorbance values relative to control group were calculated according to this formula: (ControlOD 485, 528 -experimental group OD 485, 528 )/ ControlOD 485, 528 ×100%.
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Real-time quantitative PCR (qPCR)
After 7 days of culture, total RNAs were isolated with Trizol reagent (Cat. No 15596-026, Invitrogen). The first strand cDNA was synthesized with Reverse Transcription Reagent Kit (takara code DRR037A). qPCR was performed with SYBR ® Premix Ex TaqTM (Cat.# RR420R). Delta-delta Ct method was used to analyze the data. Primer sequences are listed in Table 1 . All the experiments were repeated independently three times.
Statistical analysis
The data are expressed as mean ± SD. Statistical correlation of data was checked for significance by One-Way ANOVA and Post Hoc Turkey HSD for multiple comparisons. Differences with P < 0.05 were considered significant. These analyses were performed using SPSS 16.0 software (SPSS Inc., Chicago, IL, USA).
Results
The effects of Osthole on the ALP activity in rat MSCs
Osteoblastic induction of rat MSCs was maintained for one or two weeks. ALP staining showed that the signal in Osthole-treated MSCs was significantly hindered compared with the negative control at day 7 and day 14 respectively (Fig. 1A, 1B) . The ALP activities were further investigated, showing that the activities were also decreased in MSCs cultured with Osthole compared with the negative control and Osthole works here in a dose-dependent manner (Fig. 1C) .
The influences of Osthole on the mineralized nodule formation and calcium influx in rat MSCs
To investigate the effects of Osthole on the mineralization potential of MSCs, calcified nodule formation was evaluated by Alizarin Red-S staining at day 21 after osteogenic culture. We observed that calcified nodules in Osthole groups appeared small in size compared with the control, and such effect was concentration dependent (Fig. 2A) . The increase of intercellular calcium depends upon two different mechanisms [16] . Furthermore, a rise in the intracellular Ca 2+ levels caused by extracellular Ca 2+ concentration serves as a signal in regulating the differentiation [17] . The cells were incubated with the induction medium for six hours, and the intracellular calcium was visualized by Fluo4-AM probe. We observed that the fluorescence intensity was decreased after stimulation with osteogenic medium containing increased concentrations of Osthole, confirming the negative stimulatory effect of Osthole on the mineralization (Fig. 2B, 2C ).
Osthole treatment resulted in a dramatic reduction in osteoblastic gene expression
An increase in ALP activity and the mineralized nodule formation are indispensable to osteogenic differentiation. To further study the effect of Osthole on osteoblastic differentiation of rat MSCs, we analyzed the expression of osteoblastic genes by quantitative PCR. Our results revealed that Osthole treatment resulted in a dramatic reduction in the expression of osteoblastic genes including Col1a1, Col1a2, OCN, ALP, Runx2, Osterix, OPN, and OPG (Fig. 3) , further suggesting a significant inhibitory role of Osthole in osteoblastic differentiation of MSCs.
Osthole treatment affected the osteogenesis-associated signaling pathways
To further understand the underlying mechanism of the inhibitory role of Osthole in osteoblastic differentiation, we screened the osteogenesis-associated signaling pathways: Wnt/β-catenin, MAPK pathway, PI3K/Akt and BMPs/Smad1/5/8. The phosphorylation levels of these pathway downstream proteins were analyzed by western blot after Osthole treatment for 1 hour, 2 hours and 3 hours. Osthole treatment down-regulated the expressions of β-catenin, TCF4, and LEF, with a significant reduction in p-ERK1/2 expression (Fig. 4A,  4C ). However, Osthole promoted the expression of P-β-catenin (Fig. 4B) . In addition, Osthole treatment did not obviously influence the expression levels of p-Smad1/5/8, p-AKT(T308), p-AKT(S473), and p-P38MAPK (Fig. 4B, 4D) . 
The influence of Osthole removal on osteoblast differentiation
Osthole exhibited the inhibitory effect on osteoblast differentiation of rat MSCs. We further analyzed whether MSCs can recover the differentiation potential after Osthole removal from the induction medium. The results showed that the ALP activities in Osthole-R group or Osthole group were much lower than those in control group. However, no significant difference could be seen in between Osthole-R group and Osthole group (Fig. 6A) . Mineralized nodule formation was inhibited evidently in Osthole groups (Fig. 6B) , further confirmed by a reduction in expression of osteogenic genes after Osthole treatment. In addition to Runx2, expressed at early stage (day 7) of osteogenic differentiation to promote cell maturation and calcification, which is therefore considered as an important indicator for early osteogenesis [21] [22] [23] . In this study, Osthole significantly suppressed the rat MSCs ALP activities on day 7 and day 14 after cocultureed in osteogenic medium, confirming its primary contribution to the early stages of osteogenic differentiation. Mineralized nodule is typically observed as a late phase marker for terminal differentiation. MSCs can be stained for mineral deposition by Alizarin red [24] . Here we noted the negative impact of Osthole on the development of mineralized nodules by detecting the calcium influx with Fluo4-AM probe.
Our further observation of Osthole-induced MSCs on day 7 indicates a clear reduction in mRNA expression of osteoblast-specific genes, such as transcription factors RUNX2 (one of the key factors to trigger the osteogenic differentiation cascade [25] and Osterix (a downstream protein of Runx2 and required for the differentiation of MSCs into osteoblasts [26] ), Type I collagen (the main component of bone matrix and its degradation always results in bone loss [27, 28] ), osteocalcin [29] , and OPN [30] , coinciding completely with our previous results of both ALP activities and calcified nodules.
The osteogenic differentiation of MSCs undergoes a complex process orchestrated by multiple signaling pathways. Recent studies in rabbit and human MSCs revealed the importance of PI3K/Akt pathway in promoting cell proliferation and osteoblast differentiation [31, 32] . A serine/threonine kinases family MAPK has an essential role in regulating cell proliferation and differentiation, and accumulating experimental data have uncovered that MAPK signaling pathway is closely associated with osteogenic differentiation. As a pre-requisite for MSC differentiation, inhibition of actin polymerization decreased osteogenic differentiation 
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of MSC by targeting p38 MAPK [33] . miR-21 modulation of Erk1/2-MAPK signaling pathway regulated the process of MSC differentiation [34] . Ghrelin-mediated activation of Erk1/2 pathway accelerated the growth of rabbit MSCs [35] . Quercetin was also demonstrated to promote the osteogenic differentiation of rat MSCs by activating MAPK cascade [36] . Thus, these findings implicate the Erk1/2-MAPK signaling to be an essential controller of bone formation. Bone morphogenetic proteins (BMPs) are master regulators of osteoblast differentiation [14, 37] . Secreted BMPs bind receptors to activate Smad transcription factors, which in turn control the expression of target genes [38, 39] . Additionally, altered expression of Wnt signaling pathway components was observed in osteogenic differentiation of MSCs isolated from osteoarthritis patients. Further studies implicate some natural components extracted from plants to have potential for the promotion of the MSC differentiation towards osteoblasts [40] [41] [42] .
In general, the activity of a signaling pathway can be reflected by detecting the expression and/or activities of its downstream target proteins. From data presented in this study, we observed that the Osthole in osteogenic differentiation of MSCs dramatically inhibites the Wnt/β-catenin and Erk1/2-MAPK singaling pathways rather than the p38 MAPK, BMPs/ Smad1/5/8 and PI3K/Akt mediated signaling pathways.
Despite advances in MSCs-mediated tissue engineering, the challenge remains for the high survival and functional ability. Enhancement of MSC survival and functional ability would be the key for potential applications of MSCs in tissue regeneration [43] . High-densities MSCs were essential to promote the establishment of cell-cell contacts with formation of multicellular clusters stabilized by endogenous ECM, and also to stimulate osteogenic differentiation [44] . Gelatin microsphere-mediated aggregation of MSCs enhanced their osteogenic differentiation [45] . Aged human MSCs displayed the reduced proliferation and differentiation potential when compared with those from young donors [46] . Therefore, MSC proliferation was largely believed to be critical for osteogenic differentiation. In this study, Osthole evidently inhibited the proliferation of rat MSCs by down-regulating the expression of cell proliferation markers PCNA and CyclinD1, which is consistent with our previous data evaluated by FACS and CCK8 [47] . Thus, the results of our studies indicate that Osthole suppressed the osteogenic differentiation of MSCs, possibly in part by the Osthole-induced reduction in cell proliferation.
To further confirm whether Osthole prevents MSCs from osteogenic differentiation through inhibiting MSC proliferation, two additional experiments were conducted in this study. First of all, Osthole was removed from the medium on day 7 during the induction process, and MSCs continued to be cultured for 14 days. We observed that the ALP activities and the expression of osteogenic genes were down-regulated consistently in between Osthole-R group and Osthole group, suggesting that Osthole removal, to some degree, alleviate the inhibition extent of osteoblast differentiation especially the expression of osteogenic transcription factors Runx2 and Osterix compared with the continuous effect of Osthole on MSCs. Calcified nodules, as the mature marker for osteogenesis, was not formed efficiently in Osthole-removal (Osthole-R) group and Osthole group, providing an indication that Osthole removal on day 7 failed to induce the terminal differentiation of MSCs. Thus, these observations suggest that MSC proliferation play a vital role in the subsequent initiation of differentiation. Secondly, MSCs at the beginning of induction were seeded at high density reaching 100% confluence, and maintained in induction medium for 7 days or 21 days. Both Osthole-L group and Osthole-H group exhibited the decreased ALP activities and calcified nodule formation, and the reduction in expressions of osteogenic genes, indicating that the inhibition of osteoblast differentiation by Osthole is not dependent on MSC proliferation alone. We noticed that MSCs converged when cells reached 100% confluence, and calcified nodules were formed from the confluence site during the process of cell differentiation. However, we did not investigate the evident converge of MSCs in the presence of Osthole even after 100% confluence reached. Therefore, we made a preliminary conclusion that the failed confluence might be the second factor for osteogenic differentiation. Additionally, we observed that an increase in MSC density alone significantly accelerated cell differentiation (control-H versus control-L), confirming an essential role of cell proliferation for osteoblast differentiation.
It has been reported that Osthole promoted the differentiation and maturation of osteoblasts [11] [12] [13] [14] . However, our observations in this study seem controdictory to other reported findings, which are as follows: Firstly, the MSC proliferation was inhibited by Osthole. Secondly, the activity of Erk1/2-MAPK pathway was down-regulated efficiently by Osthole. Thirdly, the differentiation and maturation of MSCs towards osteoblasts were disrupted by Osthole. The possible explanation for the distinction described above is that MSCs share the similar biological properties with cancer cells [48] . It is not difficult to explain that Osthole interrupts the proliferation of MSCs which conforms to the inhibitory effect
